Home › Kanser sa Prostate › Georgia › Atlanta
Pag-aaral pangklinika para sa Kanser sa Prostate sa Atlanta, GA
Isang pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Atlanta. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Nagre-recruitPhase 1
- Emory University, Atlanta
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Nagre-recruitPhase 3
- Northside Hospital, Atlanta
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Atlanta VA Medical Center, Decatur · 6 mi ang layo
Addressing Health Literacy With a Tailored Survivorship Care Plan
Nagre-recruit
- Grady Memorial Hospital, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Atlanta VA Medical Center, Atlanta
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Nagre-recruitPhase 2
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
Nagre-recruitPhase 4
- Emory University, Atlanta
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
Nagre-recruitPhase 1
- Emory University Winship Cancer Institute, Atlanta
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
Nagre-recruitPhase 1
- Emory Winship Cancer Institute, Atlanta
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Nagre-recruitPhase 2/3
- Emory University, Atlanta
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Nagre-recruitPhase 1
- Emory University School of Medicine - Winship Cancer Institute, Atlanta
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Nagre-recruitPhase 2
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur · 6 mi ang layo
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
Nagre-recruitPhase 2
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur · 6 mi ang layo
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Nagre-recruitPhase 3
- Emory University School of Medicine- Grady Campus ( Site 0103), Atlanta
- Winship Cancer Institute, Emory University ( Site 0003), Atlanta
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Nagre-recruitPhase 3
- Grady Health System, Atlanta
- Emory Proton Therapy Center, Atlanta
- Emory University Hospital Midtown, Atlanta
- at 3 pa
Prostate Active Surveillance Study
Nagre-recruitObservasyonal na pag-aaral
- Emory University, Atlanta
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Nagre-recruitPhase 1
- Emory University - Winship Cancer Institute, Atlanta
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Nagre-recruitPhase 1
- Emory University, Atlanta
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Nagre-recruitPhase 1/2
- Emory University Hospital, Atlanta
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Nagre-recruitPhase 2
- Winship Cancer Institute, Emory University, Atlanta
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Emory University, Atlanta
An Investigational Scan (18F-rhPSMA-7.3 PET-mpMRI) for Targeted Prostate Biopsy Using TRUS-MR Fusion Technique
Nagre-recruitPhase 2
- Emory University Hospital, Atlanta
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Nagre-recruitPhase 3
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- at 3 pa
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Nagre-recruitObservasyonal na pag-aaral
- Morehouse School of Medicine, Atlanta
- Emory Winship Cancer Institute, Atlanta
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Nagre-recruitPhase 1/2
- Emory University Hospital, Atlanta
T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer
Nagre-recruitPhase 2
- Emory University, Atlanta
REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial
Nagre-recruitPhase 3
- Emory Proton Therapy Center, Atlanta
- Winship at Emory Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- at 1 pa
Study of AZD0754 in Participants With Metastatic Prostate Cancer
Nagre-recruitPhase 1/2
- Research Site, Atlanta
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer
Nagre-recruit
- Emory University Hospital/Winship Cancer Institute, Atlanta
Improving Health Literacy in African-American Prostate Cancer Patients
Nagre-recruit
- Atlanta VA Medical Center, Atlanta
- Grady Memorial Hospital, Atlanta
- Emory University, Atlanta
- at 1 pa
Evaluation of a Targeted Magnetic Resonance Imaging Contrast Agent in Prostate Cancer Patients
Nagre-recruitPhase 1/2
- Emory University, Atlanta
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Research Site 114, Atlanta
- Research Site 139, Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Atlanta
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Nagre-recruitPhase 3
- Grady Health System, Atlanta
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- at 2 pa
Pag-aaral para sa Kanser sa Prostate sa ibang lungsod
- New York City, NY103 pag-aaral
- Houston, TX76 pag-aaral
- Los Angeles, CA61 pag-aaral
- Boston, MA59 pag-aaral
- St. Louis, MO46 pag-aaral
- Chicago, IL45 pag-aaral
- San Francisco, CA45 pag-aaral
- Philadelphia, PA44 pag-aaral
- Baltimore, MD43 pag-aaral
- Nashville, TN43 pag-aaral
- Seattle, WA42 pag-aaral
- Washington, DC38 pag-aaral
Iba pang pag-aaral sa Atlanta
- Kanser (lahat ng uri)49 pag-aaral
- Non-Small Cell Lung Cancer47 pag-aaral
- Multiple Myeloma42 pag-aaral
- Kanser sa Suso41 pag-aaral
- Acute Myeloid Leukemia31 pag-aaral
- Kanser sa Ovary29 pag-aaral
- Colorectal Cancer29 pag-aaral
- Kanser sa Baga29 pag-aaral
- Metastatic Cancer28 pag-aaral
- Major Depressive Disorder25 pag-aaral
- Pagkabigo ng Puso25 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg24 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.